PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

106 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
21.
Gu, F.* et al.: Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia. Int. J. Cancer 141, 1794-1802 (2017)
22.
Pötzl, J. et al.: Reversal of tumor acidosis by systemic buffering reactivates NK cells to express IFN-γ and induces NK cell-dependent lymphoma control without other immunotherapies. Int. J. Cancer 140, 2125-2133 (2017)
23.
Smida, J. et al.: Genome-wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma. Int. J. Cancer 141, 816-828 (2017)
24.
Harnicek, D. et al.: Hyperthermia adds to trabectedin effectiveness and thermal enhancement is associated with BRCA2 degradation and impairment of DNA homologous recombination repair. Int. J. Cancer 139, 467-479 (2016)
25.
Consonni, D.* et al.: Lung cancer risk among bricklayers in a pooled analysis of case-control studies. Int. J. Cancer 136, 360-371 (2015)
26.
Ermolayev, V. et al.: Early recognition of lung cancer by integrin targeted imaging in K-ras mouse model. Int. J. Cancer 137, 1107-1118 (2015)
27.
Rohrmann, S.* et al.: Meat and fish consumption and the risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition. Int. J. Cancer 136, E423–E431 (2015)
28.
Seubert, B.* et al.: Tetraspanin CD63 acts as a pro-metastatic factor via β-catenin stabilization. Int. J. Cancer 136, 2304-2315 (2015)
29.
Daniel, C. ; Gerlach, K.* ; Väth, M.* ; Neurath, M.F.* & Weigmann, B.*: Nuclear factor of activated T cells - a transcription factor family as critical regulator in lung and colon cancer. Int. J. Cancer 134, 1767-1775 (2014)
30.
Hömberg, N. et al.: CD40-independent NK-cell help promotes dendritic cell vaccine-induced T-cell immunity against endogenous B-cell lymphoma. Int. J. Cancer 135, 2825-2833 (2014)
31.
Jansen, L.* et al.: Socioeconomic deprivation and cancer survival in Germany: An ecological analysis in 200 districts in Germany. Int. J. Cancer 134, 2951-2960 (2014)
32.
Lehmann, F.M. et al.: Targeting high-grade B cell lymphoma with CD19-specific T cells. Int. J. Cancer 135, 1153-1164 (2014)
33.
Prinz, P.U. et al.: NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention. Int. J. Cancer 135, 1832-1841 (2014)
34.
Seibold, P.* et al.: Enterolactone concentrations and prognosis after postmenopausal breast cancer: Assessment of effect modification and meta-analysis. Int. J. Cancer 135, 923-933 (2014)
35.
Thor, T.* et al.: MiR-34a deficiency accelerates medulloblastoma formation in vivo. Int. J. Cancer 136, 2293-2303 (2014)
36.
Work, M.E.* et al.: Changes in mammographic density over time in breast cancer cases and women at high risk for breast cancer. Int. J. Cancer 135, 1740-1744 (2014)
37.
Kuhn, T.* et al.: Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition: A nested case-control study. Int. J. Cancer 133, 1689-1700 (2013)
38.
Rohrmann, S.* et al.: Meat and fish consumption and risk of pancreatic cancer: Results from the European Prospective Investigation into Cancer and Nutrition. Int. J. Cancer 132, 617-624 (2013)
39.
Szczyrba, J.* et al.: Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma. Int. J. Cancer 132, 775-784 (2013)
40.
Appolloni, I.* et al.: Antagonistic modulation of gliomagenesis by Pax6 and Olig2 in PDGF-induced oligodendroglioma. Int. J. Cancer 131, E1078-E1087 (2012)